| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $86.7M | -11.5% |
| SG&A Expense | $29.2M | -11.9% |
| Operating Income | -$115.9M | +11.6% |
| Pre-tax Income | -$111.1M | +10.4% |
| Income Tax | $0 | — |
| Net Income | -$111.1M | +10.4% |
| EPS (Basic) | -$1.31 | +22.0% |
| EPS (Diluted) | -$1.31 | +22.0% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $4.3M | -90.5% |
| Short-term Investments | $57.1M | -3.1% |
| Current Assets | $67.4M | -39.6% |
| Total Assets | $119.9M | -29.7% |
| Current Liabilities | $16.0M | -29.7% |
| Total Liabilities | $27.1M | -12.9% |
| Stockholders' Equity | $92.9M | -33.4% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$90.5M | +11.3% |
| Capital Expenditures | $1.0M | -17.3% |
| Investing Cash Flow | $1.1M | -97.7% |
| Financing Cash Flow | $47.7M | +1079.3% |
| Free Cash Flow | -$91.5M | +11.4% |